Turning a Vicious Cycle Into a Virtuous One
The Education Network to Advance Cancer Clinical Trials (ENACCT) conducted a review of over 70 articles, studies and reports published in the last 5 years and concluded that there are 7 strategic questions that sites who hope to improve their accrual must answer. This 3-part series is designed to guide clinical trial teams at any type of institution through a comprehensive assessment of their clinical trials program to identify areas for change. The assessment and approaches described are relevant to both cancer and non-cancer clinical trials.
- Is our vision, strategy and culture conducive to a robust clinical trials program?
- Are we selecting the right trials and initiating them in a timely fashion?
- Do we have the appropriate accrual policies and are our procedures efficient?
- Are our researchers and staff communicating effectively with each other and with patients?
- Does our team have the necessary skills and tools to accrue efficiently and effectively?
- Are we using the right measures to track and improve our performance?
- Are we doing everything we can in our community to improve awareness, understanding, and receptivity to clinical trials?
- Part 1 describes the rationale and the opportunity for sites to improve their cancer clinical trial accrual by conducting a critical self-assessment.
- Part 2 describes the metrics that can be used to analyze patients, protocols, and processes in the clinical trials program.
- Part 3 focuses on the types of problems that may be identified in each of the 7 critical dimensions and strategies to resolve them.